Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)

SHA:603363 Revenue

Fujian Aonong Biological Technology Group Incorporation had revenue of 2.32B CNY in the quarter ending June 30, 2026, with 6.50% growth. This brings the company's total for the last twelve months to 9.04B, up 12.09% year-over-year. In the year 2025, Fujian Aonong Biological Technology Group Incorporation had annual revenue of 8.47B, down -3.29%. That makes Fujian Aonong Biological Technology Group Incorporation the 6,355th largest company in the world by revenue and 881st in China.

• Revenue (ttm): 9.04B
• Revenue Growth: +12.09%
• P/S Ratio: 0.81
• Revenue / Employee: 1.76M
• Employees: 5,126
• Market Cap: 7.29B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Feed and Animal Protection 6.57B 70.8%
• Feeding 1.57B 16.9%
• Food 1.09B 11.8%
• Trading 31.15M 0.3%
• Others 13.00M 0.1%

Fiscal year ended Dec 31, 2025 See the full SHA:603363 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.47B	-287.93M	-3.29%
Dec 31, 2024	8.76B	-10.69B	-54.97%
Dec 31, 2023	19.46B	-2.16B	-9.97%
Dec 31, 2022	21.61B	3.57B	19.82%
Dec 31, 2021	18.04B	6.52B	56.62%

Data Source: S&P Global Market Intelligence Last updated: Aug 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error